Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease

Neurology

Volumn 63, Issue 3, 2004, Pages 589-590

  Linazasoro, Gurutz ^a,b   Van Blercom, Nadege ^a   Castro, Alfonso ^b   Dapena, Maria Dolores ^b  

^a HOSPITAL QUIRÓN   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIPYRETIC AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CEFTAZIDIME; CREATINE KINASE; DANTROLENE; LEVODOPA; PRAMIPEXOLE; SELEGILINE; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALIGNANT SYNDROME; NEUROSURGERY; ON OFF PHENOMENON; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC DEEP BRAIN STIMULATION; SUBTHALAMIC NUCLEUS; SUBTHALAMOTOMY; WITHDRAWAL SYNDROME;

EID: 3543096299     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000133409.53486.FF     Document Type: Article

References (4)

1. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deepbrain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
2. Brown RG. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:689.
3. Linazasoro G. Subthalamic deep-brain stimulation for advanced Parkinson's disease: all that glitters is not gold. J Neurol Neurosurg Psychiatry 2003;74:827.
4. Mizuno Y, Takubo H, Mizuta E, Kuno S. Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism 2003;9:S3-S9.